Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Accumulated Expenses: 2022-2024

Historic Accumulated Expenses for Praxis Precision Medicines (PRAX) over the last 3 years, with Dec 2024 value amounting to $23.8 million.

  • Praxis Precision Medicines' Accumulated Expenses rose 39.92% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.6 million, marking a year-over-year increase of 39.92%. This contributed to the annual value of $23.8 million for FY2024, which is 220.43% up from last year.
  • As of FY2024, Praxis Precision Medicines' Accumulated Expenses stood at $23.8 million, which was up 220.43% from $7.4 million recorded in FY2023.
  • Praxis Precision Medicines' Accumulated Expenses' 5-year high stood at $23.8 million during FY2024, with a 5-year trough of $7.4 million in FY2023.
  • In the last 3 years, Praxis Precision Medicines' Accumulated Expenses had a median value of $15.8 million in 2022 and averaged $15.7 million.
  • In the last 5 years, Praxis Precision Medicines' Accumulated Expenses plummeted by 53.21% in 2023 and then soared by 220.43% in 2024.
  • Praxis Precision Medicines' Accumulated Expenses (Yearly) stood at $15.8 million in 2022, then crashed by 53.21% to $7.4 million in 2023, then spiked by 220.43% to $23.8 million in 2024.